V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential

Author： Jirathitikal V.   Sooksathan P.   Metadilogkul O.   Bourinbaiar A.S.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.7, 2003-01, pp. : 624-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy

By Koesling J.   Lucas B.   Develioglou L.   Aebischer T.   Meyer T.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 413-420

Elsevier

Access to resources Recommend Favorite

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

By Betti M.   Voltan R.   Marchisio M.   Mantovani I.   Boarini C.   Nappi F.   Ensoli B.   Caputo A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3408-3419

Elsevier

Access to resources Recommend Favorite

Quantifying the population impact of a prophylactic Helicobacter pylori vaccine

By Rupnow M.F.T.   Shachter R.D.   Owens D.K.   Parsonnet J.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 879-885

Elsevier

Access to resources Recommend Favorite

Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120

By Veljkovic V.   Johnson E.   Metlas R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 473-474

Elsevier

Access to resources Recommend Favorite

Modeling the economic benefits of an AIDS vaccine

By Bishai D.   Lin M.K.   Kiyonga C.W.B.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 526-531

Elsevier

Access to resources Recommend Favorite